Venogram abnormal and Joint pain

Summary:

Joint pain is found among people with Venogram abnormal, especially for people who are female, 20-29 old.

The study analyzes which people have Joint pain with Venogram abnormal. It is created by eHealthMe based on reports of 46 people who have Venogram abnormal from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Venogram abnormal?

Venogram abnormal is found to be associated with 12 drugs and 5 conditions by eHealthMe. Check the latest studies of Venogram abnormal.

What is Joint pain?

Joint pain is found to be associated with 3,330 drugs and 5,207 conditions by eHealthMe. Check the latest studies of Joint pain.



On Jul, 20, 2026

46 people who have Venogram Abnormal and Joint Pain are studied.

Would you have Joint pain when you have Venogram abnormal?

Gender of people who have Venogram Abnormal and experienced Joint Pain *:

  • female: 65.91 %
  • male: 34.09 %

Age of people who have Venogram Abnormal and experienced Joint Pain *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 34.15 %
  • 30-39: 14.63 %
  • 40-49: 26.83 %
  • 50-59: 24.39 %
  • 60+: 0.0 %

Common co-existing conditions for these people *:

  1. Nuclear Magnetic Resonance Imaging Brain: 27 people, 58.70%
  2. Nuclear Magnetic Resonance Imaging Abdominal: 9 people, 19.57%
  3. Depression: 6 people, 13.04%
  4. Pain: 5 people, 10.87%
  5. Oedema Peripheral (superficial swelling): 4 people, 8.70%
  6. Computerised Tomogram Abdomen: 4 people, 8.70%
  7. High Blood Pressure: 3 people, 6.52%
  8. Diabetes: 3 people, 6.52%
  9. Anaemia Of Chronic Disease: 3 people, 6.52%
  10. Phosphorus Metabolism Disorder: 3 people, 6.52%

Common drugs taken by these people *:

  1. Magnevist: 44 people, 95.65%
  2. Omniscan: 35 people, 76.09%
  3. Renagel: 35 people, 76.09%
  4. Clonidine: 22 people, 47.83%
  5. Optimark: 21 people, 45.65%
  6. Norvasc: 21 people, 45.65%
  7. Prednisone: 20 people, 43.48%
  8. Prohance: 20 people, 43.48%
  9. Multihance: 20 people, 43.48%
  10. Prograf: 19 people, 41.30%

Common symptoms for these people *:

  1. Nephrogenic Systemic Fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease): 46 people, 100.00%
  2. Skin Hypertrophy (skin cells enlarges): 40 people, 86.96%
  3. Skin Induration (an abnormally hard spot or area on the skin): 38 people, 82.61%
  4. Skin Hyperpigmentation (disorders affect the colour of your skin): 35 people, 76.09%
  5. Pain In Extremity: 34 people, 73.91%
  6. Joint Range Of Motion Decreased (disease of joint movement): 29 people, 63.04%
  7. Oedema Peripheral (superficial swelling): 27 people, 58.70%
  8. Pain: 27 people, 58.70%
  9. Skin Tightness: 25 people, 54.35%
  10. Mobility Decreased (ability to move is reduced): 20 people, 43.48%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Joint pain?

- Check whether Joint pain is associated with a drug or a condition


Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Joint pain:

All the conditions that are associated with Joint pain:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Joint pain and Venogram abnormal, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: